- Home
- HIMS vs RVMD Comparison
HIMS vs RVMD Comparison
Compare HIMS & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HIMS | RVMD |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 7.5B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | HIMS | RVMD |
|---|---|---|
| Price | $37.08 | $78.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 18 |
| Target Price | $44.90 | ★ $77.11 |
| AVG Volume (30 Days) | ★ 17.6M | 2.1M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.76 | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $2,210,958,000.00 | N/A |
| Revenue This Year | $62.21 | N/A |
| Revenue Next Year | $18.79 | $714.50 |
| P/E Ratio | $69.31 | ★ N/A |
| Revenue Growth | ★ 78.02 | N/A |
| 52 Week Low | $23.97 | $29.17 |
| 52 Week High | $72.98 | $81.49 |
Technical Indicators
Market Signals| Indicator | HIMS | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 73.68 |
| Support Level | $36.65 | $77.54 |
| Resistance Level | $40.74 | $81.49 |
| Average True Range (ATR) | 1.83 | 2.51 |
| MACD | 0.47 | -0.48 |
| Stochastic Oscillator | 31.52 | 75.46 |
Price Performance
Historical ComparisonAbout HIMS Hims & Hers Health Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.